Factors such as the rising geriatric population, increase in the volume of surgeries and sports-related injuries, and increasing awareness about the medical implications of adhesions are expected to drive market growth during the forecast period. The untapped emerging markets are expected to present growth opportunities for players in the market.
What the Market Looks Like?
Predicted to grow at a CAGR of 7.2 % during the forecast period, the global Adhesion Barrier Market is estimated to reach USD 806.4 Billion by the end of 2023. In 2018, North America dominated the market.
Based on product, the adhesion barrier market is broadly segmented into synthetic adhesion barriers and natural adhesion barriers. In 2018, the synthetic adhesion barriers segment accounted for the largest share of this market. The large share of this market can be attributed to the large number of commercially available synthetic adhesion barriers and their higher utilization (as compared to natural adhesion barriers) by surgeons in various surgeries. Advantages such as cost effectiveness and bioabsorbable properties of synthetic adhesion barriers make them more preferred as compared to natural adhesion barriers.
Based on formulation, the adhesion barrier market is segmented into film formulations, liquid formulations, and gel formulations. In 2018, the film formulations segment held the largest share of this market. The largest share of this segment is attributed to the growing number of surgical procedures utilizing film-form adhesion barriers and the higher adoption of film-form adhesion barriers by surgeons due to their low cost. The availability of clinical evidence supporting the safety and efficacy of these forms of adhesion barriers further boost the growth of this market.
Based on application, the adhesion barrier market is further segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). Gynecological surgeries dominated the adhesion barrier market in 2018. The large share of the gynecological surgeries segment is attributed to the increasing number of hysterectomy and C-section surgeries and the growing adoption of film-form and gel-form adhesion barriers for open and laparoscopic gynecological surgeries, respectively.
Download PDF Brochure @
What Drives the Market?
The growth of the global market for Adhesion Barrier is primarily influenced by the following factors:
Geographical growth scenario of Adhesion Barrier Market
Geographically, the Adhesion Barrier market has been studied for North America, Europe. North America accounted for the largest share of the adhesion barrier market in 2018, followed by Europe. Increase in the incidence of chronic diseases associated with aging population, increase in the volume of surgical procedures, well-established healthcare services, and higher public and private healthcare expenditure are responsible for the largest share of North America in the adhesion barriers market. market.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Leading market players and strategies adopted
The pr.ominent players in the Adhesion Barrier market include Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Please share your specific interest to serve you better, Request for Bundle Reports @ https://www.marketsandmarkets.com/RequestBundleReport.asp?id=208132543
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.